If you have tested positive for COVID-19, you might be feeling a bit of fear along with the regular symptoms, especially if you’re at increased risk for developing complications that may result in hospitalization. Although there are some treatments for the symptoms of COVID-19, few antiviral drugs are available to help treat COVID-19 in patients with mild to moderate infections.
Meridian is conducting a study for an investigational drug intended to help treat COVID-19. In this placebo-controlled study, participants may receive a non-active placebo to see how it compares to the investigational drug.
Must be 18 or older
Must have confirmed SARS-CoV-2 infection within the past 72 hours
Must NOT have received a COVID-19 vaccine
Must be experiencing at least ONE symptom of COVID-19, e.g., cough; fever; shortness of breath; diarrhea; headache; sore throat; chills; loss of smell/taste
Be generally healthy and age 18 to 59 OR;
Have at least ONE of the following characteristics and/or conditions: Age >60; BMI >25; a smoker; have an immune suppressive disease; diabetes; kidney disease; cardiovascular disease; hypertension; chronic lung disease; Sickle Cell disease; and/or cancer
Will receive compensation for study-related time
Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240 (NY) or (712) 639-6200 (NE).
Submit your information
Grand Island: Meridian Clinical Research, 2444 West Faidley Avenue, Grand Island, NE 68803
Endwell: Meridian Clinical Research, 415 Hooper Road, Endwell, NY 13760
After you submit your information, a Meridian enrollment specialist will contact you.
Participating in a study is an important decision — we’re here to help you before, during, and after studies.
Please note: Health insurance is NOT required to join.
Will I benefit from this study?
You are not guaranteed to benefit from being in a clinical study. However, information gathered in this study may help uncover better ways to treat condition(s) for you and others worldwide.
Is participation voluntary after I submit my information?
Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, your role in the trial, potential side effects, tests that will be performed, and the number of visits required. You will need to sign an informed consent form to join the study only after you fully understand your role in the study.
Will I get a physical exam?
If you join the study, you will receive a physical exam. You may also receive specific exams or tests — the results of which will be shared with you.
Will I receive compensation?
While participation in a clinical study is voluntary, you may be reimbursed for your study-related travel and expenses. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible reimbursement with you.
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.